Auxesis Pharma Holding AB (publ) is a Swedish pharmaceutical company specializing in topical pain relief and skin irritation treatments. Based on our own patents, we develop innovative OTC and RX medicines for both humans and animals – designed to act fast, provide lasting effect, and be easily accessible. 

Our first product platform, ASA.P®, is the world’s first stabilized liquid form of acetylsalicylic acid (ASA) for direct application on the skin. It offers rapid pain relief and anti-inflammatory effect in minutes – a breakthrough in a category where today’s alternatives provide only temporary cooling. With a clear roadmap of new products in development and a strong, experienced leadership team, Auxesis is building long-term value in the global market for topical pain relief. Our interdisciplinary expertise spans pharmaceutical R&D, regulatory processes, commercialization and market access – ensuring that innovation successfully reaches the end user. 

Our mission: redefine the global market for topical pain relief and improve quality of life for end users worldwide.

Auxesis Pharma

Org chart

Teams

Offices

Auxesis Pharma

Org chart

Teams

Offices

Related companies